Restoring functional neurofibromin by protein transduction

Area of Science:

• Molecular Biology
• Cell Biology
• Genetics

Background:

• Neurofibromatosis 1 (NF1) is a genetic disorder caused by loss-of-function mutations leading to reduced neurofibromin protein levels.
• Neurofibromin, a large Ras-GAP protein, regulates the RAS-MAPK pathway and cellular mechanosensing.
• NF1 haploinsufficiency affects cell proliferation and mechanosensory functions.

Purpose of the Study:

• To investigate the feasibility of replacing deficient neurofibromin in cells.
• To assess the functionality of transduced neurofibromin in NF1 models.
• To explore protein transduction as a therapeutic approach for NF1.

Main Methods:

• Recombinant full-length neurofibromin was produced in insect cells and purified.
• Protein transduction into cultured human fibroblasts utilized cell-penetrating peptides and photochemical internalization.
• NF1 patient-derived fibroblasts and NF1 siRNA-treated normal fibroblasts were used as models.

Main Results:

• Successful intracellular uptake and cytoplasmic translocation of recombinant neurofibromin were achieved.
• Transduced neurofibromin demonstrated functional Ras-GAP activity.
• Restoration of mechanosensory function was observed in treated cells.
• Cellular effects of NF1 haploinsufficiency were reverted in vitro.

Conclusions:

• Recombinant neurofibromin protein replacement is effective in reversing cellular deficits associated with NF1 haploinsufficiency.
• Protein transduction represents a promising strategy for potential NF1 treatment.
• This in vitro study validates a novel therapeutic avenue for the monogenic disease NF1.